Cellipont Bioservices, a contract development and manufacturing organization (CDMO) specializing in cell therapies and gene-modified cell therapies, has appointed Stella Vnook as chief scientific officer.   Vnook is a biopharmaceutical executive with 20+ years of leadership experience driving transformational change for global clinical development portfolios from early-stage R&D to commercialization. She has extensive background in cell therapy, as a company founder and patent owner of mul...